ABOUT THE PRODUCT
A Target-Site Blocker (TSB) targeting CXCR4, designed to reprogram endothelial and smooth muscle cells to combat atherosclerosis.
Information is owner-confirmed
Last updated 5 months ago
Price range
Other products/services from Cardivia Labs Inc
SIRT6-TBS
Biotechnology
N/A
Cardivia Labs Inc
United States (US)